CRDO drops 13.5% in a week as analysts trim targets and the CTO sells

Credo Technology Group designs the high-speed interconnect chips that sit at the heart of AI data centre networks. Its shares closed at $171.51 on Tuesday, down 13.5% over the past week, a move that lines up with a broad semiconductor sell-off but leaves the stock nursing a steeper loss than most of its closest peers.

The week's decline was not an outlier in the sector, but it was towards the worse end. ENTG and LSCC each fell around 11.3%, ALAB dropped 12.5%, and FORM and MKSI shed 15.9% and 14.7% respectively. So CRDO sits roughly in the middle of its correlated peer group on the week. The one-month picture is milder at -2.5%, which means most of the damage came in a concentrated burst rather than a gradual drift.

Short positioning adds a layer of complexity to this picture. Short interest has climbed 29% over the past month to 5.6% of the free float, a level that puts meaningful weight on the other side of the trade. That monthly build is the more telling figure: it preceded this week's drop and suggests some participants were already positioned for weakness. Over the past week alone, short interest eased back 5.8%, so at least some of that bearish positioning was being covered even as the stock fell. The borrow market is extremely loose. Availability is running at around 2,929%, meaning there is far more capacity to lend shares than there are shares already shorted. Cost to borrow has collapsed to 0.24%, roughly half the level of a week ago and among the lowest readings of the past 30 days. Those conditions do not suggest a crowded or strained short book.

Options traders have turned modestly more defensive. The put/call ratio is at 1.02, sitting 1.75 standard deviations above its 20-day average of 0.97. That is elevated relative to recent history, though not at the kind of extreme that would signal outright fear: the 52-week high for the ratio is 1.36, so the current reading is notable but not off the charts. The uptick in put demand arrived in tandem with the share price weakness, consistent with portfolio hedging rather than a directional bet being built in size.

Analyst coverage remains broadly constructive, but the tone has cooled since CRDO reported its Q1 FY27 quarter on September 1, when the stock dropped 27% in a single session. That result prompted a wave of target reductions across the Street, with JP Morgan trimming to $310 from $335, BofA cutting to $275 from $340, and Evercore ISI moving to $292 from $325. All three maintained positive ratings. Stifel, in the most recent adjustment on October 5, lowered its target to $310 from $350 while holding its Buy. The consensus mean target is around $279, which implies roughly 63% upside from the current price. At a stock trading near $171, that gap looks wide, and it reflects how far the shares have fallen since most targets were set rather than a fresh bullish case. Rosenblatt is the lone Neutral on recent record, with a $235 target. The bull case rests on FY27 revenue growth of around 70% year-on-year, gross margins near 68%, and a potential $600 million contribution from optical products. The bear case centres on rising competition from Marvell and Broadcom in the 1.6T AEC market, customer concentration (the top four accounts drove around 87% of revenue in the most recent quarter), and the risk that the DustPhotonics acquisition compresses margins as it is consolidated.

On the ownership side, CTO Chi Fung Cheng sold just over 18,000 shares on October 13, across multiple transactions, at prices ranging from roughly $188 to $199 per share. The total value was in the region of $3.7 million. Every transaction was conducted under a pre-arranged 10b5-1 plan, so the sales were scheduled in advance rather than being a discretionary market call. Cheng's last disclosed 13G filing showed his stake had already slipped from 5.1% to 4.7% as of April this year. BlackRock remains the largest institutional holder at around 9.4% of shares, though its own 13G filing from July showed the position had trimmed from 9.0% to 7.7% at that point. T. Rowe Price and Jennison Associates both added materially in the quarter to end-September, with T. Rowe adding over 2.2 million shares.

Earnings are next scheduled for December 2, 42 days away. The two most recent prints produced sharp negative reactions: the September 1 result brought a 27% single-day decline and a further 26% loss over the following five days, and the October 12 result generated an 8.4% drop on the day and 20% over five days. With the stock already pricing in a significant reset from its earlier highs, the December print will be watched for whether the optical and 1.6T AEC ramp is tracking the ambitious FY27 targets management has laid out.